Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Novo Nordisk lowered the list price on various insulin products, including pre-filled insulin pens and vials. The company suggested that this would mean patients would pay $25-35 for their insulin.

To determine how accurately and reproducibly small doses are delivered, 1, 2, 5, and 10 U doses of soluble insulin (100 U/ml) were dispensed in random order 15 times from five new NovoPens (1.5 ml), ...

Remember a time when your only treat was an orange-wrapped Breakaway after school, and eating between meals signified the decline of civilisation? If so, you grew up before the golden (wonder) age of ...

A crowd of about 40 gathered Saturday outside an Orlando Tesla showroom to protest company owner Elon Musk and his governmental initiative,… Hunters Cove in Crystal River is arguably one of the ...